Search Results 1201-1210 of 17067 for monoclonal antibody
... Antibody Drug Conjugate, in Participants With Advanced Solid Tumors Rochester, MN. The purpose of this study is to evaluate the safety, tolerability ...
Exposure to another investigative drug (small molecules as well as monoclonal antibodies) ... The minimum interval since exposure to any other (non-antibody) ...
It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. This medicine is also used to treat immunoglobulin G4-related disease (IgG4-RD), a ...
It works by causing your body to produce its own protection (antibodies) against the disease. Respiratory syncytial virus can cause serious breathing ...
Mayo Clinic Laboratories' comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from ...
Prior cancer-directed immunotherapy within 4 weeks, including monoclonal antibodies against PD-1 receptor or ligand;; Use of an experimental vaccine within 2 ...
iNHL (including FL of grades 1-3A and marginal zone lymphoma) refractory to rituximab or to any other anti-CD20 monoclonal antibodies ... Prior anti-CD20 antibody ...
For this research study, the use of brentuximab vedotin in newly diagnosed Hodgkin lymphoma is considered investigational. Brentuximab vedotin is an antibody ...
Vasculitis — giant cell arteritis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and all other forms of vasculitis. · Systemic autoimmune ...
Anti-CD20 monoclonal antibodies within 7 days prior to leukapheresis 11. Venetoclax within 4 days prior to leukapheresis 12. Idelalisib or duvelisib within ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.